Avenue Therapeutics, Inc. (ATXI) vs CERo Therapeutics Holdings, Inc. (CERO)
Avenue Therapeutics, Inc. and CERo Therapeutics Holdings, Inc. are both Biotechnology companies. Avenue Therapeutics, Inc. is the larger, with a market value of $680.0K against $140.0K — 4.9× the size. Avenue Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; CERo Therapeutics Holdings, Inc. trades at 0.0×. Across the 8 metrics below, CERo Therapeutics Holdings, Inc. leads on 5 and Avenue Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ATXI | CERO | Biotechnology median |
|---|---|---|---|
| Gross margin | — | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (163.30%) | 453.76% | (57.72%) |
| Return on assets | (90.50%) | (2,352.32%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack